Initial experience with linear focused shockwave treatment for erectile dysfunction: a 6-month follow-up pilot study

Int J Impot Res. 2015 May-Jun;27(3):108-12. doi: 10.1038/ijir.2014.41. Epub 2014 Dec 4.

Abstract

Low-intensity shockwaves (LISW) are known to produce revascularization and have been in evaluation and in use to treat erectile dysfunction (ED). The present single-arm pilot study is aimed to assess the safety and efficacy of a dedicated shockwave device (Renova) on vasculogenic ED patients. Fifty-eight patients with mild to severe ED were treated by LISW and their erectile function was evaluated by the International Index of Erectile Function-Erectile Function Domain (IIEF-EF), Sexual Encounter Profile and Global Assessment Questions questionnaires, at baseline and at 1, 3 and 6 months post treatment. The average IIEF-EF increased significantly from 14.78 at baseline to 21.93 at 3 months post treatment and stabilized at 22.26 at 6 months post treatment. Out of 58 patients, 47 (81%) had a successful treatment. No adverse events were reported during the treatment and the follow-up duration. In conclusion, it suggests that the performance of LISW could add a new advanced treatment for ED.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Electroshock / adverse effects
  • Electroshock / instrumentation
  • Electroshock / methods*
  • Erectile Dysfunction / therapy*
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Penis
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Pilot Projects
  • Prospective Studies
  • Surveys and Questionnaires
  • Treatment Outcome

Substances

  • Phosphodiesterase 5 Inhibitors